Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 59K
2: EX-99.1 Miscellaneous Exhibit HTML 8K
7: R1 Document and Entity Information Statement HTML 71K
10: XML IDEA XML File -- Filing Summary XML 12K
8: XML XBRL Instance -- jpm-20230117_htm XML 52K
9: EXCEL IDEA Workbook of Financial Reports XLSX 9K
4: EX-101.DEF XBRL Definitions -- jpm-20230117_def XML 52K
5: EX-101.LAB XBRL Labels -- jpm-20230117_lab XML 124K
6: EX-101.PRE XBRL Presentations -- jpm-20230117_pre XML 53K
3: EX-101.SCH XBRL Schema -- jpm-20230117 XSD 19K
11: JSON XBRL Instance as JSON Data -- MetaLinks 17± 28K
12: ZIP XBRL Zipped Folder -- 0000019617-23-000082-xbrl Zip 29K
(State
or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. employer identification no.)
i383 Madison Avenue,
iNew
York,
iNew York
i10179
(Address of principal
executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (i212) i270-6000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
i☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon
stock
iJPM
iThe New York Stock Exchange
iDepositary
Shares, each representing a one-four hundredth interest in a share of 5.75% Non-Cumulative Preferred Stock, Series DD
iJPM PR D
iThe New York Stock Exchange
iDepositary
Shares, each representing a one-four hundredth interest in a share of 6.00% Non-Cumulative Preferred Stock, Series EE
iJPM PR C
iThe New York Stock Exchange
iDepositary
Shares, each representing a one-four hundredth interest in a share of 4.75% Non-Cumulative Preferred Stock, Series GG
iJPM PR J
iThe New York Stock Exchange
iDepositary
Shares, each representing a one-four hundredth interest in a share of 4.55% Non-Cumulative Preferred Stock, Series JJ
iJPM PR K
iThe New York Stock Exchange
iDepositary
Shares, each representing a one-four hundredth interest in a share of 4.625% Non-Cumulative Preferred Stock, Series LL
iJPM PR L
iThe New York Stock Exchange
iDepositary
Shares, each representing a one-four hundredth interest in a share of 4.20% Non-Cumulative Preferred Stock, Series MM
iGuarantee
of Callable Fixed Rate Notes due June 10, 2032 of JPMorgan Chase Financial Company LLC
iJPM/32
iThe New York Stock Exchange
Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 (d) Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
JPMorgan Chase & Co. (the “Firm”) elected Alicia Boler Davis as a director, effective March 20, 2023. Ms. Davis is the Chief Executive Officer of Alto Pharmacy. Ms. Davis' appointment to a board committee will be disclosed when determined. She
was also elected a director of JPMorgan Chase Bank, N.A. and a manager of JPMorgan Chase Holdings LLC, and may be elected a director of such other subsidiary or subsidiaries as may be determined from time to time.
Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language).
104
Cover
Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
